CHICAGO and JACKSONVILLE, Fla., April 28, 2011 /PRNewswire/ -- Diversified Clinical Services, Inc. (DCS), the world's largest wound care management services provider, will provide an ONC-ATCB-certified Electronic Health Record (EHR) and Practice Management solution from Allscripts (NASDAQ: MDRX) as part of i-heal 2.0®, a clinical productivity solution being developed for use by DCS' network of over 325 hospitals and 2,600 physicians.
The new i-heal 2.0 will leverage DCS' unrivaled scope and scale, and the proven technological expertise and innovation leadership of Allscripts to further improve patient outcomes and enhance operational efficiencies. i-heal 2.0 will include:
The Allscripts Electronic Health Record and Practice Management solution customized for wound care
Real-time wound care specific clinical decision support
DCS' clinical algorithms and workflows
Outcomes tracking and quality reporting
i-heal 2.0 is an important clinical component of DCS' integrated technology suite, which includes referral development, clinical research and benchmarking, business analytics, human resources management, among a variety of other unique technologies and processes.
i-heal 2.0 will allow for secure and efficient connectivity between Wound Care Centers in DCS' Network and virtually all hospital-based EHR systems. i-heal 2.0 will integrate the Allscripts solution with DCS' evidence-based Clinical Practice Guidelines to deliver a real-time clinical decision support system, giving providers the information they need, when they need it, to effectively treat wound patients. Hospital-based Wound Care Centers in DCS' clinical network will also have the unique advantage of meeting all "meaningful use" provisions soon to be required of Medicaid and Medicare providers who seek to qualify for EHR incentive payments under the American Recovery and Reinvestment Act (ARRA).
"i-heal 2.0 will provide an unmatched best-in-class ambulatory EHR and practice management solution seamlessly integrated with outcomes tracking and benchmarking capabilities, dramatically increasing the quantity and quality of the information we are able to gather on the effectiveness of different wound healing approaches," said Jeff Nelson, Chief Executive Officer of Diversified Clinical Services. "This will help us accelerate the pace of improvement in both the quality of care and cost-effectiveness of treating the over seven million Americans suffering from chronic wounds today. We chose to partner with Allscripts, not only because of the success they've had enhancing the quality of care and removing costs for 180,000 physicians, but also for their ability to connect with all major inpatient EHR systems used in hospitals nationwide."
"As the recognized leader in wound care services, DCS is taking the next step toward improving the mobility, quality of life and overall well-being of patients with chronic wounds," said Glen Tullman, Chief Executive Officer of Allscripts. "By combining the clinical and operational expertise of DCS and the health information technology leadership of Allscripts, our alliance creates a powerful tool to assist providers in this highly specialized field, while enabling physicians to qualify for meaningful use."
Dell will host the Allscripts Electronic Health Record and Practice Management solution for DCS using a secure datacenter, simplifying the technical configuration required at the Wound Care Centers and ensuring 24/7 enterprise-level support and information security.
Diversified Clinical Services, Inc. (DCS) is the leading provider of outpatient wound care management services to more than 325 hospitals nationwide. DCS provides specialized wound care through evidence-based Clinical Practice Guidelines. DCS' comprehensive program allows hospitals to realize increased ancillary revenues, build physician relationships, support key hospital surgical programs and provide best-in-class clinical outcomes for the growing base of underserved chronic wound patients. To learn more about Diversified Clinical Services, please visit www.diversifiedcs.com.
Allscripts (NASDAQ: MDRX) provides innovative solutions that empower all stakeholders across the healthcare continuum to deliver world-class outcomes. The company's Electronic Health Record, Computerized Physician Order Entry and other clinical, financial, connectivity and information solutions for hospitals, physicians and post-acute organizations are the essential technologies that enable a Connected Community of Health™. To learn more about Allscripts, please visit www.allscripts.com, Twitter, Facebook and YouTube.
This press release contains forward-looking statements within the meaning of the federal securities laws. Statements regarding future events or developments, our future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements with the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on our results of operations or financial condition.
Such risks, uncertainties and other factors include, among other things: the possibility that the expected synergies, efficiencies and cost savings of the merger with Eclipsys Corporation ("Eclipsys") will not be realized, or will not be realized within the expected time period; potential difficulties or delays in achieving platform and product integration and the connection and movement of data among hospitals, physicians, patients and others; the risk that the Allscripts and Eclipsys businesses will not be integrated successfully; competition within the industries in which we operate; failure to achieve certification under the Health Information Technology for Economic and Clinical Health Act could result in increased development costs, a breach of some customer obligations and could put us at a competitive disadvantage in the marketplace; the volume and timing of systems sales and installations, the length of sales cycles and the installation process and the possibility that our products will not achieve or sustain market acceptance; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; competitive pressures including product offerings, pricing and promotional activities; our ability to establish and maintain strategic relationships; undetected errors or similar problems in our software products; the outcome of any legal proceeding that has been or may be instituted against us; compliance with existing laws, regulations and industry initiatives and future changes in laws or regulations in the healthcare industry, including possible regulation of our software by the U.S. Food and Drug Administration; the possibility of product-related liabilities; our ability to attract and retain qualified personnel; the implementation and speed of acceptance of the electronic record provisions of the American Recovery and Reinvestment Act of 2009; maintaining our intellectual property rights and litigation involving intellectual property rights; risks related to third-party suppliers and our ability to obtain, use or successfully integrate third-party licensed technology; and breach of our security by third parties. See our Annual Report on Form 10-K for the fiscal year ended May 31, 2010 and other public filings with the SEC for a further discussion of these and other risks and uncertainties applicable to our business. The statements herein speak only as of their date and we undertake no duty to update any forward-looking statement whether as a result of new information, future events or changes in expectations.